NFKB1 and diabetic kidney disease: Baicalein prevented DKD development in high‐fat diabetes/STZ‐induced T2D rats via its antioxidant, antihyperglycemic, and anti‐inflammatory activities by suppressing NF‐κB (Ahad et al. 2014).